Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: Case-control study in China

Liver International

Volumn 30, Issue 2, 2010, Pages 215-221

  Tao, Lian Yuan ^a   He, Xiao Dong ^a   Qu, Qiang ^a   Cai, Lei ^a   Liu, Wei ^a   Zhou, Li ^a   Zhang, Shang Ming ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Extrahepatic cholangiocarcinoma; Hepatitis B virus; Intrahepatic cholangiocarcinoma; Risk factor

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CASE CONTROL STUDY; CHINA; CHOLECYSTECTOMY; CHOLELITHIASIS; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DRINKING BEHAVIOR; EXTRAHEPATIC CHOLANGIOCARCINOMA; FAMILY HISTORY; FEMALE; HEPATITIS B; HUMAN; INTERVIEW; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MEDICAL RECORD; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING;

BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BILE DUCTS, INTRAHEPATIC; CASE-CONTROL STUDIES; CHINA; CHOLANGIOCARCINOMA; CHOLECYSTECTOMY; CHOLECYSTOLITHIASIS; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEPATITIS B, CHRONIC; HOSPITALS, UNIVERSITY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77950619381     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02149.x     Document Type: Article

References (34)

1. Khan SA, Taylor-Robinson SD, Toledano MB. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002, 37:806-13.
2. McLean L, Patel T. Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States (2006). Liver Int 26:1047-53.
3. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001, 33:1353-7.
4. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002, 2:10.
5. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004, 24:115-25.
6. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004, 40:472-7.
7. Taylor-Robinson SD, Toledano MB, Arora S. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 2001, 48:816-20.
8. West J, Wood H, Logan RF, Quinn M, Aithal GP. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer 2006, 94:1751-8.
9. Hsing AW, Gao YT, Devesa SS, Jin F, Fraumeni JF. Rising incidence of biliary tract cancers in Shanghai, China. Int J Cancer 1998, 75:368-370.
10. Andreotti G, Chen J, Gao YT. Serum lipid levels and the risk of biliary tract cancers and biliary stones: a population-based study in China. Int J Cancer 2008, 122:2322-9.
11. Hsing AW, Bai Y, Andreotti G. Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Int J Cancer 2007, 121:832-8.
12. Hsing AW, Gao YT, Han TQ. Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 2007, 97:1577-82.
13. Hsing AW, Gao YT, McGlynn KA. Biliary tract cancer and stones in relation to chronic liver conditions: a population-based study in Shanghai, China. Int J Cancer 2007, 120:1981-5.
14. Hsing AW, Sakoda LC, Rashid A. Body size and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 2008, 99:811-5.
15. Hsing AW, Zhang M, Rashid A. Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer 2008, 122:1849-53.
16. Zhou YM, Yin ZF, Yang JM. Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J Gastroenterol 2008, 14:632-5.
17. Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chin Med J 2007, 120:2159-73. Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association.
18. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005, 128:620-6.
19. Shaib YH, El-Serag HB, Nooka AK. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 2007, 102:1016-21.
20. Welzel TM, Mellemkjaer L, Gloria G. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer 2007, 120:638-41.
21. Hadr SC, Murphy BL, Schable CA. Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens. J Clin Microbiol 1984, 19:521-5.
22. Perumal V, Wang J, Thuluvath P, Choti M, Torbenson M. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol 2006, 37:1211-6.
23. Paterlini P, Gerken G, Nakajima E. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990, 323:80-5.
24. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002, 9:243-57.
25. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis 2002, 2:479-86.
26. Donato F, Gelatti U, Tagger A. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 2001, 12:959-64.
27. Kobayashi M, Ikeda K, Saitoh S. Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000, 88:2471-7.
28. Takegoshi K, Su Q, Omata M. Cholangiocarcinoma with a background of hepatitis B virus-associated cirrhosis. Intern Med 2001, 40:382-5.
29. Shin HR, Lee CU, Park HJ. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 1996, 25:933-40.
30. Lee TY, Lee SS, Jung SW. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol 2008, 103:1716-20.
31. Alison MR. Liver stem cells: implications for hepatocarcinogenesis. Stem Cell Rev 2005, 1:253-60.
32. Liu XF, Zou SQ, Qiu FZ. Pathogenesis of cholangiocarcinoma in the porta hepatis and infection of hepatitis virus. Hepatobiliary Pancreat Dis Int 2003, 2:285-9.
33. Tomimatsu M, Ishiguro N, Taniai M. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer 1993, 72:683-8.
34. Wu J, Zhang W, Han LL. A sero-epidemiological study on hepatitis B among general population in Beijing. Zhonghua Gan Zang Bing Za Zhi 2008, 28:555-7.